Vincent Anzalone | VP, IR |
Christopher Anzalone | President and CEO |
Bruce Given | COO and Head of R&D |
Ken Myszkowski | CFO |
Katherine Xu | William Blair |
Elemer Piros | Cantor |
Ladies and gentlemen, welcome to the Arrowhead Pharmaceutical's Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference call over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.